tirzepatide phase 1 Patients who took the anti-obesity drug for almost two years lost 25 percent of their body weight and maintained improvements in metabolic and cardiovascular health, according to a new 3 Tirzepatide modulates the regulation of

4 Mr Bs history of substance-induced psychosis underscores his vulnerability to the psychoactive effects of kratom

Meals become smaller, snacking decreases, and the constant preoccupation with food that many people with obesity experience begins to fade

K., Harper, M.-E

Quando il grasso viscerale si riduce, spiega Colao, migliorano numerosi parametri clinici : dalla funzionalit epatica a quella renale, fino alla salute cardiovascolare

Tirzepatide activates dual GIP and GLP-1 pathways to support appetite management and metabolic health

30 Even though chronic malnutrition is common among liver disease patients, there is a subset of malnourished patients, namely those with the psychiatric illness anorexia nervosa, which merits special attention